Health Care M&A Deal Volume Slips in Q1:2016, As Deal Value Surges, According to Health Care M&A News

NORWALK, CT – May 3, 2016 – Health care merger and acquisition activity began to slow down in the first quarter of 2016. Compared with the fourth quarter of 2015, deal volume decreased 7%, to 351 transactions. Deal volume was also down 7% compared with the same quarter the year before. Combined spending in the first quarter reached $79.5 billion, an increase of 87% compared with the $42.5 billion spent in the previous quarter, according to Health Care M&A News. 

Health care services represented 62% of the first quarter’s transaction total, slightly lower than the 67% share reported in the previous quarter. The decline is due in part to slow-downs in nearly all of the services sectors, resulting in a 14% decline in deal volume in Q1:16 on the services side. The Home Health & Hospice and Rehabilitation sectors, however, saw higher deal-making activity with increases of 50% and 43%, respectively.

 On the technology side, transaction growth in the eHealth and Medical Devices sectors continued, up 17% and 7%, respectively, over the previous quarter, and both up 35% compared with the first quarter in 2015.

 “The slowdown in deal volume in the first quarter of 2016 might simply be fatigue setting in after a record-setting year in 2015,” said Lisa E. Phillips, editor of Health Care M&A News. “Also, some buyers are still figuring out where the best opportunities are, as the shift to value-based reimbursements gains momentum.”

M&A activity is likely to reflect this recent slowdown in the coming quarter. “A lot of private equity firms that made big exits last year now have a lot of cash that they’d like to put to work,” Ms. Phillips said. “That said, valuations are still too high for many buyers. They’re going to wait and see if prices start to come down.”

For more information on The Health Care M&A Information Source or Health Care M&A News, or for a membership to any of Irving Levin Associates’ services, call 800-248-1668. Irving Levin Associates, Inc., established in 1948, is headquartered in Norwalk, Connecticut and is online at www.levinassociates.com.  This privately held corporation publishes annual and quarterly research reports, monthly and weekly newsletters, and maintains merger and acquisition databases on the health care and senior housing markets. If you would like to receive future releases, please email pressreleases@levinassociates.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.